...Medivir sold its wholly owned subsidiary Cross Pharma AB to MedCap's Unimedic AB subsidiary for SEK125... ...& Co acted as legal advisors in the transaction. Medivir AB (SSE:MVIR B), Huddinge, Sweden MedCap AB...
...for its rPA102 anthrax vaccine in December 2006. The week before the scheduled vote, investor MedCap... ...momentum for the transaction. At March 19, the firm held about 4.8% of VaxGen (NASDAQ:VXGN). MedCap...
...Medivir sold its wholly owned subsidiary Cross Pharma AB to MedCap's Unimedic AB subsidiary for SEK125... ...& Co acted as legal advisors in the transaction. Medivir AB (SSE:MVIR B), Huddinge, Sweden MedCap AB...
...for its rPA102 anthrax vaccine in December 2006. The week before the scheduled vote, investor MedCap... ...momentum for the transaction. At March 19, the firm held about 4.8% of VaxGen (NASDAQ:VXGN). MedCap...